Results for tag: "Pseudomonas Aeruginosa Pneumonia Drug"

Pseudomonas Aeruginosa Pneumonia is a type of pneumonia caused by the bacterium Pseudomonas aeruginosa. Treatment of this infection typically involves antibiotics, such as carbapenems, fluoroquinolones, and aminoglycosides. The Pseudomonas Aeruginosa Pneumonia Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. The Pseudomonas Aeruginosa Pneumonia Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Companies in this market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the development of treatments for this type of infection. Show Less Read more